# Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma

> **NCT05111314** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** Gallium Ga 68 Gozetotide
- **PROCEDURE:** Hepatic Artery Embolization
- **PROCEDURE:** Positron Emission Tomography and Computed Tomography Scan

## Key facts

- **NCT ID:** NCT05111314
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02-11
- **Primary completion:** 2023-08-14
- **Final completion:** 2023-08-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI requested
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05111314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05111314, "Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05111314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*